ACS Chemical Neuroscience · 2025 · 12 citations · 17 references
Life SciencesMolecular BiologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurodegenerationMotor Neuron DiseasesNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersActive Dna DemethylationBap1 LossBrca1 InactivationIron DistributionMitochondrial NeuropathologyParkinson's Disease ModelsParkinsonian DegenerationProtein Oxidation In Neurodegeneration
Background: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the involvement of ferroptosis in its pathological mechanism. In this study, the effects and mechanism of BRCA1-associated protein 1 (BAP1) on neuronal ferroptosis in PD were evaluated. Methods: A PD mouse model was constructed by injecting mice with MPTP. Nissl staining, immunohistochemistry, immunofluorescence, and Prussian blue staining evaluated histopathology and iron distribution. The PD cell model was constructed by subjecting SK-N-SH cells to MPP + . The m6A level of BAP1 was assessed by MeRIP. mRNA levels of BAP1, FTO, IGF2BP1, METTL3, YTHDF2, and SLC7A11 were evaluated utilizing RT-qPCR. Protein levels of BAP1, FTO, IGF2BP1, METTL3, YTHDF2, SLC7A11, and p53 were measured by Western blot. Cell viability was assessed using CCK-8 assay, and TUNEL was used for assessing apoptosis. The levels of MDA, GSH, SOD, and Fe 2+ were also measured. The interactions among molecules were verified using RIP assay, dual luciferase reporter assay, and ChIP assay. Results: SK-N-SH cells treated with MPP + showed a decrease in overall m6A levels of BAP1. FTO facilitated m6A demethylation of BAP1, leading to an increased level of expression of BAP1. m6A-binding protein, YTHDF2 recognized and decayed methylated mRNA of BAP1, leading to the reduced BAP1 stability. The FTO/BAP1 axis promoted MPP + -induced ferroptosis by suppressing SLC7A11. BAP1, in collaboration with p53, reduced the level of expression of SLC7A11. Knocking down BAP1 mitigated ferroptosis in an MPTP mouse model. Conclusion: m6A-mediated modification of BAP1 regulates neuronal ferroptosis by cooperating with p53 to decrease the level of SLC7A11. Thus, BAP1 may be a potential therapeutic target for PD treatment.
17
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang, Ning Kon, Tongyuan Li et al. · Nature · 2015 · 3.4K citations · Full text
Medicine, Cancer Biology, Oncology +14
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Yilei Zhang, Jiejun Shi, Xiaoguang Liu et al. · Nature Cell Biology · 2018 · 1K citations
ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis
Feng He, Peng Zhang, Junlai Liu et al. · Journal of Hepatology · 2023 · 365 citations · Full text
Down-Regulation of m6A mRNA Methylation Is Involved in Dopaminergic Neuronal Death
Xuechai Chen, Chunyu Yu, Minjun Guo et al. · ACS Chemical Neuroscience · 2019 · 218 citations